The Hypervirulent Strain of Clostridium Difficile: NAP1/B1/027 - A Brief Overview.
clostridium difficile
diarrhea
nap1/b1/027
recurrence
ribotype 027
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
29 Jan 2019
29 Jan 2019
Historique:
entrez:
11
4
2019
pubmed:
11
4
2019
medline:
11
4
2019
Statut:
epublish
Résumé
Clostridium difficile is a gram-positive bacterium notorious for causing epidemic diarrhea globally with a significant health burden. The pathogen is clinically challenging with increasing antibiotic resistance and recurrence rate. We provide here an in-depth review of one particular strain/ribotype 027, commonly known as NAP1/B1/027 or North American pulsed-field gel electrophoresis type 1, restriction endonuclease analysis type B1, polymerase chain reaction ribotype 027, which has shown a much higher recurrence rate than other strains.
Identifiants
pubmed: 30967977
doi: 10.7759/cureus.3977
pmc: PMC6440555
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
e3977Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Infect Dis. 1992 Sep;166(3):561-7
pubmed: 1323621
Lancet. 2005 Sep 24-30;366(9491):1079-84
pubmed: 16182895
Clin Infect Dis. 2007 Jan 15;44(2):238-44
pubmed: 17173224
Eur J Clin Microbiol Infect Dis. 2007 Oct;26(10):695-703
pubmed: 17647032
J Clin Microbiol. 2008 Apr;46(4):1530-3
pubmed: 18287318
PLoS One. 2008 Mar 19;3(3):e1812
pubmed: 18350149
Clin Gastroenterol Hepatol. 2009 Aug;7(8):868-873.e2
pubmed: 19465153
World J Gastroenterol. 2010 Jan 14;16(2):139-42
pubmed: 20066732
Arch Intern Med. 2010 May 10;170(9):784-90
pubmed: 20458086
Am J Gastroenterol. 2010 Nov;105(11):2327-39; quiz 2340
pubmed: 20606676
Anaerobe. 2010 Dec;16(6):560-5
pubmed: 20887795
Eur J Clin Microbiol Infect Dis. 2011 Nov;30(11):1371-81
pubmed: 21468685
Korean J Lab Med. 2011 Jul;31(3):191-6
pubmed: 21779194
Antimicrob Agents Chemother. 2011 Nov;55(11):5194-9
pubmed: 21844318
J Clin Microbiol. 2011 Dec;49(12):4040-6
pubmed: 21956985
BMC Res Notes. 2012 Mar 21;5:159
pubmed: 22436392
Clin Microbiol Infect. 2012 Jul;18(7):635-45
pubmed: 22536816
Clin Infect Dis. 2012 Dec;55(12):1661-8
pubmed: 22972866
J Pharm Pract. 2013 Oct;26(5):464-75
pubmed: 24064435
JAMA. 2013 Oct 23;310(16):1661-3
pubmed: 24150445
Gut Microbes. 2014 Jan-Feb;5(1):15-27
pubmed: 24253566
J Med Microbiol. 2014 Feb;63(Pt 2):322-4
pubmed: 24287669
Clin Infect Dis. 2014 May;58(10):1394-400
pubmed: 24604900
BMC Infect Dis. 2014 Sep 15;14:502
pubmed: 25223337
Surg Clin North Am. 2014 Dec;94(6):1335-49
pubmed: 25440127
Clin Infect Dis. 2015 Jul 15;61(2):233-41
pubmed: 25828993
PLoS One. 2015 May 28;10(5):e0129079
pubmed: 26020926
Antimicrob Agents Chemother. 2015 Oct;59(10):6266-73
pubmed: 26248357
Antimicrob Agents Chemother. 2017 Feb 23;61(3):
pubmed: 28052855
N Engl J Med. 2017 Jan 26;376(4):305-317
pubmed: 28121498
PLoS One. 2017 Jan 26;12(1):e0170640
pubmed: 28125650
IDCases. 2017 Mar 06;8:27-28
pubmed: 28331803
Lancet Infect Dis. 2017 Jul;17(7):735-744
pubmed: 28461207
J Microbiol Immunol Infect. 2018 Jun;51(3):344-351
pubmed: 28583353
Anaerobe. 2017 Dec;48:1-6
pubmed: 28645479
J Antimicrob Chemother. 2017 Dec 1;72(12):3462-3470
pubmed: 28961905
Clin Microbiol Infect. 2018 Jul;24(7):724-731
pubmed: 29066403
Clin Microbiol Infect. 2018 Aug;24(8):877-881
pubmed: 29174729
Diagn Microbiol Infect Dis. 2018 Jun;91(2):105-111
pubmed: 29456070
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48
pubmed: 29462280
Microb Drug Resist. 2018 May;24(4):386-392
pubmed: 29485939
Int J Med Microbiol. 2018 Apr;308(3):364-377
pubmed: 29490877
Adv Med Sci. 2018 Sep;63(2):290-295
pubmed: 29665558
Infect Immun. 1988 Sep;56(9):2299-306
pubmed: 3137166